PharmaControl Corp said itacquired Private Formulations Inc from &lt;Revco D.S. Inc> for sixmln dlrs in cash, a 13,550,000 dlr promissory note and warrantsto buy 200,000 PharmaControl common shares.    PharmaControl said the purchase price was financed, alongwith one mln dlrs in working capital, through securedinstitutional financing.    The company said betweenm 11,550,000 dlrs and 12,550,000dlrs f the principal amount of the Revco note, plus accruedinterest, is payable June 30. The balance is payable over threeyears.    PharmaControl said it expects to make the payment due toRevco from proceeds of a proposed offering of units consistingof convertible subordinated debenturers and common stockcurrently on file with the Securities and Exchange Commission.    Upon closing of the public offering, the company said, itexpects the secured institutional financing to increase to atotal of 12 mln dlrs.    Private Formulations is primarily engaged in themanufacture and distribution of vitamins and private labelover-the-counter pharmaceutical products. Reuter&#3;